CC[C@@H](c1ccccc1)n1c(=O)n2n(c1=O)[C@@H]1[C@H](CC2)C(=O)[C@@H]2O[C@@H]2[C@H]1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?